Literature DB >> 19121442

Effect of catheter ablation for isolated paroxysmal atrial fibrillation on longitudinal and circumferential left ventricular systolic function.

Patricia Reant1, Stephane Lafitte, Hanane Bougteb, Frederic Sacher, Aude Mignot, Herve Douard, Pierre Blanc, Meleze Hocini, Jacques Clementy, Michel Haissaguerre, Raymond Roudaut, Pierre Jais.   

Abstract

Isolated paroxysmal atrial fibrillation (AF) is commonly associated with left ventricular (LV) diastolic dysfunction but normal radial systolic contraction. We aim to investigate LV systolic function more precisely using 2-dimensional strain technique in patients with isolated paroxysmal AF and to evaluate evolution of longitudinal, circumferential, and radial (or transverse) strain components after catheter ablation of AF. Thirty patients with isolated paroxysmal AF were investigated by echocardiographic studies before and at 1-day, 1-month, 6-month, and 12-month intervals after radiofrequency ablation. Left heart dimensions and LV systolic and diastolic functions were evaluated at each time interval. LV systolic function was quantified by LV ejection fraction and by 2-dimensional strain evaluation, giving regional and global longitudinal, circumferential, transverse, and radial peak of percentage deformation. Patients with AF were compared with 30 control subjects, paired by age and by sex. Before AF ablation, LV ejection fraction, transverse and radial strains were not significantly different from control subjects. By contrast, global longitudinal and circumferential strains were significantly lower than controls (-17.7%+/-2.4% vs -21.5%+/-2.0% [p<0.01] and -16.0%+/-2.9% vs -20.7%+/-3.4% [p<0.01], respectively). At the end of follow-up, global longitudinal and circumferential strains were significantly improved (-20.8%+/-2.6% vs -17.7%+/-2.4% (p<0.01) and -18.5%+/-3.1% vs -16.0%+/-2.9% [p<0.05], respectively). Global longitudinal strain was not significantly different from normal control subjects at the end of follow-up. In conclusion, this prospective study demonstrates (1) the existence of early longitudinal and circumferential LV systolic function abnormalities in patients with isolated paroxysmal AF but normal ejection fraction and (2) reverse remodeling of these abnormalities after AF ablation.

Entities:  

Mesh:

Year:  2008        PMID: 19121442     DOI: 10.1016/j.amjcard.2008.08.070

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  14 in total

1.  Effect of catheter ablation on the left ventricular mass index and other echocardiograph parameters in atrial fibrillation patients: comparison with antiarrhythmic drug treatment.

Authors:  Ki-Hun Kim; Jin Oh Na; Gi-Byoung Nam; Eun-Sun Jin; HyungOh Choi; Sung-Hwan Kim; Kee-Joon Choi; You-Ho Kim
Journal:  J Echocardiogr       Date:  2010-10-05

2.  Effect of atrial fibrillation ablation on myocardial function: insights from cardiac magnetic resonance feature tracking analysis.

Authors:  Felix Ceelen; Ross J Hunter; Redha Boubertakh; Wieland H Sommer; Marco Armbruster; Richard J Schilling; Steffen E Petersen
Journal:  Int J Cardiovasc Imaging       Date:  2013-09-04       Impact factor: 2.357

3.  Subclinical left ventricular dysfunction and silent cerebrovascular disease: the Cardiovascular Abnormalities and Brain Lesions (CABL) study.

Authors:  Cesare Russo; Zhezhen Jin; Shunichi Homma; Mitchell S V Elkind; Tatjana Rundek; Mitsuhiro Yoshita; Charles DeCarli; Clinton B Wright; Ralph L Sacco; Marco R Di Tullio
Journal:  Circulation       Date:  2013-07-31       Impact factor: 29.690

4.  Left atrial reservoir function predicts atrial fibrillation recurrence after catheter ablation: a two-dimensional speckle strain study.

Authors:  Mahek Mirza; Giuseppe Caracciolo; Uzma Khan; Naoyo Mori; Samir K Saha; Komandoor Srivathsan; Gregory Altemose; Luis Scott; Partho Sengupta; Arshad Jahangir
Journal:  J Interv Card Electrophysiol       Date:  2011-03-22       Impact factor: 1.900

5.  Improvement of left ventricular function after successful radiofrequency catheter ablation in persistent atrial fibrillation with preserved left ventricular ejection fraction: a comprehensive echocardiographic assessment using two-dimensional speckle tracking analysis.

Authors:  Tomoo Nagai; Junko Arakawa; Akira Hamabe; Hirotsugu Tabata
Journal:  J Echocardiogr       Date:  2018-10-01

6.  Left Ventricular Systolic Dysfunction by Longitudinal Strain Is an Independent Predictor of Incident Atrial Fibrillation: A Community-Based Cohort Study.

Authors:  Cesare Russo; Zhezhen Jin; Fusako Sera; Edward S Lee; Shunichi Homma; Tatjana Rundek; Mitchell S V Elkind; Ralph L Sacco; Marco R Di Tullio
Journal:  Circ Cardiovasc Imaging       Date:  2015-08       Impact factor: 7.792

Review 7.  Effects of radiofrequency catheter ablation on left ventricular structure and function in patients with atrial fibrillation: a meta-analysis.

Authors:  Pengju Zhu; Yong Zhang; Peiqing Jiang; Zhongsu Wang; Jiangrong Wang; Xiangcui Yin; Yinglong Hou
Journal:  J Interv Card Electrophysiol       Date:  2014-06-26       Impact factor: 1.900

8.  Early detection of left ventricular systolic dysfunction using two-dimensional speckle tracking strain evaluation in healthy subjects after acute alcohol intoxication.

Authors:  Patricia Reant; Warren Chasseriaud; Xavier Pillois; Marina Dijos; Florence Arsac; Raymond Roudaut; Stephane Lafitte
Journal:  Echocardiography       Date:  2012-05-29       Impact factor: 1.724

9.  Could successful cryoballoon ablation of paroxysmal atrial fibrillation prevent progressive left atrial remodeling?

Authors:  Tamás Erdei; Mónika Dénes; Attila Kardos; Attila Mihálcz; Csaba Földesi; András Temesvári; Mária Lengyel
Journal:  Cardiovasc Ultrasound       Date:  2012-03-19       Impact factor: 2.062

10.  Left Ventricular Systolic Function Assessed by Global Longitudinal Strain is Impaired in Atrial Fibrillation Compared to Sinus Rhythm.

Authors:  Bue F Ross Agner; Michael G Katz; Zachary R Williams; Ulrik Dixen; Gorm B Jensen; Karl Q Schwarz
Journal:  J Atr Fibrillation       Date:  2017-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.